NRX Pharmaceuticals (NRXP) Capital Expenditures (2021 - 2023)
NRX Pharmaceuticals' (NRXP) quarterly Capital Expenditures came in at -$1000.0 in Q4 2023, little changed year-on-year from -$1000.0 in Q4 2022, and down 150.0% on a QoQ basis from $2000.0 in Q3 2023.
NRX Pharmaceuticals (NRXP) Capital Expenditures (2021 - 2023) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 3 years of Capital Expenditures data on file, last reported at -$1000.0 in Q4 2023.
- On a quarterly basis, Capital Expenditures changed 0.0% year-over-year to -$1000.0 in Q4 2023; TTM through Sep 2024 was -$1000.0, a 133.33% decrease from a year earlier, with the FY2023 full-year figure at $3000.0, down 70.0% from the prior year.
- Capital Expenditures for Q4 2023 stood at -$1000.0, down from $2000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for NRXP reached as high as $5000.0 in Q3 2022 and fell as low as -$2000.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $1888.9 across 3 years, with a median of $3000.0 in 2022.
- On a YoY basis, Capital Expenditures climbed as much as 33.33% in 2023 and fell as far as 166.67% in 2023.
- Year by year, Capital Expenditures stood at $4000.0 in 2021, then tumbled by 125.0% to -$1000.0 in 2022, then changed by 0.0% to -$1000.0 in 2023.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$1000.0 in Q4 2023, $2000.0 in Q3 2023, and -$2000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |